Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Curr Opin Neurobiol 9 : 293298
Financial terms of the transaction were not disclosed
While this is beneficial for the patients who need the medications for health conditions, it does reduce consistency for providers
Duncan continues
Patients who have a deteriorating response to L-dopa, experience fluctuations in response to L-dopa, or have a limited clinical response to L-dopa secondary to an inability to tolerate higher doses are appropriate candidates
A Comprehensive Review on Weight Gain following Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists for Obesity
US$ 26.97
US$ 20.17
US$ 24.96
US$ 24.16
US$ 28.38
